ANXA2 and ovarian carcinoma: Response to ATRA treatment in the ovarian cancer cell lines did not correlate with expression of ANXA2, S100A10 or retinoic acid receptor alpha (RARA) as all cell lines exhibited similar gene expression levels (Additional file 3: Figure S1a).